Emergent BioSolutions Inc (EBS)
8.10
+0.04
(+0.50%)
USD |
NYSE |
Dec 20, 16:00
8.12
+0.02
(+0.25%)
Pre-Market: 20:00
Emergent BioSolutions Profit Margin (Quarterly): 40.45% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 15.48% |
| Tonix Pharmaceuticals Holding Corp | -503.6% |
| Chimerix Inc | -88.00K% |
| Geron Corp | -93.55% |
| MAIA Biotechnology Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -35.94% |
| Return on Assets | -12.27% |
| Return on Invested Capital | -14.79% |
| Gross Profit Margin (Quarterly) | 56.80% |
| Operating Margin (Quarterly) | 22.73% |
| Return on Net Operating Assets | -14.69% |